AAPL344.07+1.11 (+0.32%) ▲|ABBV286.68+4.93 (+1.75%) ▲|ABT104.48+2.14 (+2.09%) ▲|ACN226.03+11.07 (+5.15%) ▲|ADBE250.70+10.02 (+4.16%) ▲|AMAT429.39-17.24 (-3.86%) ▼|AMD551.78-19.04 (-3.34%) ▼|AMGN440.08+13.97 (+3.28%) ▲|AMT181.38+1.98 (+1.10%) ▲|AMZN254.02-0.07 (-0.03%) ▼|AVGO337.97-8.29 (-2.39%) ▼|AXP313.46+6.51 (+2.12%) ▲|BA187.00+2.34 (+1.27%) ▲|BAC51.73+0.34 (+0.65%) ▲|BKNG166.91+6.23 (+3.88%) ▲|BLK1,113.99+40.20 (+3.74%) ▲|BMY60.99+1.71 (+2.88%) ▲|BNY141.65+4.01 (+2.91%) ▲|BRK-B527.76+1.41 (+0.27%) ▲|C122.90+0.63 (+0.52%) ▲|CAT727.18-21.80 (-2.91%) ▼|CL92.63-0.16 (-0.17%) ▼|CMCSA21.68+0.63 (+2.97%) ▲|COF199.26+4.91 (+2.52%) ▲|COP142.34+0.00 (+0.00%) ▲|COST989.72+7.72 (+0.79%) ▲|CRM244.89+8.94 (+3.79%) ▲|CSCO109.25-4.39 (-3.86%) ▼|CVS92.20+1.81 (+2.00%) ▲|CVX219.93-2.12 (-0.95%) ▼|DE655.49+5.11 (+0.78%) ▲|DHR232.28+7.59 (+3.38%) ▲|DIS111.47+2.48 (+2.27%) ▲|DUK119.39-0.25 (-0.21%) ▼|EMR160.72-0.36 (-0.22%) ▼|FDX293.58+2.30 (+0.79%) ▲|GD335.92+1.26 (+0.38%) ▲|GE309.31+2.29 (+0.75%) ▲|GEV914.45-27.33 (-2.90%) ▼|GILD159.31+5.77 (+3.76%) ▲|GM83.85+0.80 (+0.96%) ▲|GOOG345.20+1.55 (+0.45%) ▲|GOOGL349.37+1.73 (+0.50%) ▲|GS883.59+4.87 (+0.55%) ▲|HD305.83+10.32 (+3.49%) ▲|HON208.57+0.96 (+0.46%) ▲|IBM232.69+4.81 (+2.11%) ▲|INTC93.92-4.20 (-4.28%) ▼|INTU330.18+19.74 (+6.36%) ▲|ISRG427.08+6.84 (+1.63%) ▲|JNJ253.53-0.38 (-0.15%) ▼|JPM334.17-1.11 (-0.33%) ▼|KO92.36+0.58 (+0.63%) ▲|LIN494.58+1.88 (+0.38%) ▲|LLY1,265.44+56.70 (+4.69%) ▲|LMT531.33+9.10 (+1.74%) ▲|LOW195.73+7.42 (+3.94%) ▲|LRCX273.44-13.48 (-4.70%) ▼|MA617.18+13.94 (+2.31%) ▲|MCD242.82+4.51 (+1.89%) ▲|MDLZ63.56+0.99 (+1.58%) ▲|MDT95.65+1.42 (+1.51%) ▲|META738.17+0.63 (+0.08%) ▲|MMM165.59+1.13 (+0.69%) ▲|MO73.73+0.60 (+0.82%) ▲|MRK147.87+0.50 (+0.34%) ▲|MS179.71-1.81 (-0.99%) ▼|MSFT539.33+5.64 (+1.06%) ▲|MU908.73-5.41 (-0.59%) ▼|NEE78.77+0.40 (+0.51%) ▲|NFLX72.82+2.25 (+3.19%) ▲|NKE37.63+2.33 (+6.60%) ▲|NOW147.13+7.15 (+5.11%) ▲|NVDA217.38-3.92 (-1.77%) ▼|ORCL133.83+3.28 (+2.51%) ▲|PEP130.00+0.73 (+0.56%) ▲|PFE29.70+0.49 (+1.69%) ▲|PG157.64+1.11 (+0.71%) ▲|PLTR199.60-1.37 (-0.68%) ▼|PM200.43-5.15 (-2.50%) ▼|QCOM175.91+3.29 (+1.91%) ▲|RTX185.58-0.90 (-0.48%) ▼|SBUX96.07+2.82 (+3.02%) ▲|SCHW93.94-2.87 (-2.96%) ▼|SO89.28-0.11 (-0.12%) ▼|SPG203.15+4.45 (+2.24%) ▲|T23.53+0.48 (+2.08%) ▲|TMO695.27+22.07 (+3.28%) ▲|TMUS157.50-0.29 (-0.18%) ▼|TSLA360.52-6.64 (-1.81%) ▼|TXN276.87-3.78 (-1.35%) ▼|UBER70.85+1.56 (+2.25%) ▲|UNH410.32+14.70 (+3.71%) ▲|UNP288.65+2.22 (+0.78%) ▲|UPS97.52+1.74 (+1.82%) ▲|USB57.32+1.06 (+1.88%) ▲|V402.11+10.68 (+2.73%) ▲|VZ44.71+0.29 (+0.64%) ▲|WFC82.92+2.02 (+2.50%) ▲|WMT118.59+2.43 (+2.09%) ▲|XOM174.89-2.12 (-1.20%) ▼|AAPL344.07+1.11 (+0.32%) ▲|ABBV286.68+4.93 (+1.75%) ▲|ABT104.48+2.14 (+2.09%) ▲|ACN226.03+11.07 (+5.15%) ▲|ADBE250.70+10.02 (+4.16%) ▲|AMAT429.39-17.24 (-3.86%) ▼|AMD551.78-19.04 (-3.34%) ▼|AMGN440.08+13.97 (+3.28%) ▲|AMT181.38+1.98 (+1.10%) ▲|AMZN254.02-0.07 (-0.03%) ▼|AVGO337.97-8.29 (-2.39%) ▼|AXP313.46+6.51 (+2.12%) ▲|BA187.00+2.34 (+1.27%) ▲|BAC51.73+0.34 (+0.65%) ▲|BKNG166.91+6.23 (+3.88%) ▲|BLK1,113.99+40.20 (+3.74%) ▲|BMY60.99+1.71 (+2.88%) ▲|BNY141.65+4.01 (+2.91%) ▲|BRK-B527.76+1.41 (+0.27%) ▲|C122.90+0.63 (+0.52%) ▲|CAT727.18-21.80 (-2.91%) ▼|CL92.63-0.16 (-0.17%) ▼|CMCSA21.68+0.63 (+2.97%) ▲|COF199.26+4.91 (+2.52%) ▲|COP142.34+0.00 (+0.00%) ▲|COST989.72+7.72 (+0.79%) ▲|CRM244.89+8.94 (+3.79%) ▲|CSCO109.25-4.39 (-3.86%) ▼|CVS92.20+1.81 (+2.00%) ▲|CVX219.93-2.12 (-0.95%) ▼|DE655.49+5.11 (+0.78%) ▲|DHR232.28+7.59 (+3.38%) ▲|DIS111.47+2.48 (+2.27%) ▲|DUK119.39-0.25 (-0.21%) ▼|EMR160.72-0.36 (-0.22%) ▼|FDX293.58+2.30 (+0.79%) ▲|GD335.92+1.26 (+0.38%) ▲|GE309.31+2.29 (+0.75%) ▲|GEV914.45-27.33 (-2.90%) ▼|GILD159.31+5.77 (+3.76%) ▲|GM83.85+0.80 (+0.96%) ▲|GOOG345.20+1.55 (+0.45%) ▲|GOOGL349.37+1.73 (+0.50%) ▲|GS883.59+4.87 (+0.55%) ▲|HD305.83+10.32 (+3.49%) ▲|HON208.57+0.96 (+0.46%) ▲|IBM232.69+4.81 (+2.11%) ▲|INTC93.92-4.20 (-4.28%) ▼|INTU330.18+19.74 (+6.36%) ▲|ISRG427.08+6.84 (+1.63%) ▲|JNJ253.53-0.38 (-0.15%) ▼|JPM334.17-1.11 (-0.33%) ▼|KO92.36+0.58 (+0.63%) ▲|LIN494.58+1.88 (+0.38%) ▲|LLY1,265.44+56.70 (+4.69%) ▲|LMT531.33+9.10 (+1.74%) ▲|LOW195.73+7.42 (+3.94%) ▲|LRCX273.44-13.48 (-4.70%) ▼|MA617.18+13.94 (+2.31%) ▲|MCD242.82+4.51 (+1.89%) ▲|MDLZ63.56+0.99 (+1.58%) ▲|MDT95.65+1.42 (+1.51%) ▲|META738.17+0.63 (+0.08%) ▲|MMM165.59+1.13 (+0.69%) ▲|MO73.73+0.60 (+0.82%) ▲|MRK147.87+0.50 (+0.34%) ▲|MS179.71-1.81 (-0.99%) ▼|MSFT539.33+5.64 (+1.06%) ▲|MU908.73-5.41 (-0.59%) ▼|NEE78.77+0.40 (+0.51%) ▲|NFLX72.82+2.25 (+3.19%) ▲|NKE37.63+2.33 (+6.60%) ▲|NOW147.13+7.15 (+5.11%) ▲|NVDA217.38-3.92 (-1.77%) ▼|ORCL133.83+3.28 (+2.51%) ▲|PEP130.00+0.73 (+0.56%) ▲|PFE29.70+0.49 (+1.69%) ▲|PG157.64+1.11 (+0.71%) ▲|PLTR199.60-1.37 (-0.68%) ▼|PM200.43-5.15 (-2.50%) ▼|QCOM175.91+3.29 (+1.91%) ▲|RTX185.58-0.90 (-0.48%) ▼|SBUX96.07+2.82 (+3.02%) ▲|SCHW93.94-2.87 (-2.96%) ▼|SO89.28-0.11 (-0.12%) ▼|SPG203.15+4.45 (+2.24%) ▲|T23.53+0.48 (+2.08%) ▲|TMO695.27+22.07 (+3.28%) ▲|TMUS157.50-0.29 (-0.18%) ▼|TSLA360.52-6.64 (-1.81%) ▼|TXN276.87-3.78 (-1.35%) ▼|UBER70.85+1.56 (+2.25%) ▲|UNH410.32+14.70 (+3.71%) ▲|UNP288.65+2.22 (+0.78%) ▲|UPS97.52+1.74 (+1.82%) ▲|USB57.32+1.06 (+1.88%) ▲|V402.11+10.68 (+2.73%) ▲|VZ44.71+0.29 (+0.64%) ▲|WFC82.92+2.02 (+2.50%) ▲|WMT118.59+2.43 (+2.09%) ▲|XOM174.89-2.12 (-1.20%) ▼|
18.2 C
New York
Thursday, October 15, 2026

Tag: source

Davis Commodities Explores Tokenized Agricultural Trade as U.S. Stablecoin Framework Advances

Davis Commodities explores Solana and blockchain solutions for ESG-aligned, tokenized agricultural trade amid U.S. stablecoin regulation progress.

“Shelter Me: The Cancer Pioneers” Nominated for Two Daytime Emmy Awards

Nominations Include Outstanding Daytime Special and Writing Team for a Daytime Non-Fiction Program LOS ANGELES, July 11, 2025 /PRNewswire/ -- "Shelter Me: The Cancer Pioneers" has been...

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PepGen To Contact Him Directly To Discuss Their Options

Adrenal Crisis Market Analysis and Forecast Report 2025-2035 with Competitive Benchmarking of Eton Pharmaceuticals, Antares Pharma, and Pfizer

The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevalence of autoimmune diseases and corticosteroid use for chronic conditions further accelerates market demand. However, challenges such as high treatment costs, limited awareness in low-income regions, and diagnostic complexities may slow adoption in emerging markets. Between 2025-2035, advancements in diagnostic technologies and innovative therapies are expected to bolster market growth, though access issues remain crucial. Key players like Eton Pharmaceuticals, Antares Pharma, and Pfizer are leading with product innovation and strategic partnerships.
The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevalence of autoimmune diseases and corticosteroid use for chronic conditions further accelerates market demand. However, challenges such as high treatment costs, limited awareness in low-income regions, and diagnostic complexities may slow adoption in emerging markets. Between 2025-2035, advancements in diagnostic technologies and innovative therapies are expected to bolster market growth, though access issues remain crucial. Key players like Eton Pharmaceuticals, Antares Pharma, and Pfizer are leading with product innovation and strategic partnerships.

GCI promotes dialogue among civilizations to become a world trend: Global Times

BEIJING, July 11, 2025 /PRNewswire/ -- One month after the first International Day for Dialogue among Civilizations, the Ministerial Meeting of the Global Civilizations...

ZenaTech Reacts to ‘Unleashing U.S. Military Drone Dominance’ Memo — A Game-Changing Policy Directive for ZenaDrone

VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today reacts to the July 10, 2025 new policy directive from Secretary of Defense Pete Hegseth, ‘Unleashing U.S. Military Drone Dominance.’ ZenaTech confirms that under this policy directive, its entire portfolio of ZenaDrone drones qualify as Group 1–2 expendable assets and are now enabled for direct purchases by field commanders for both training and real-world missions, and they no longer need Green or Blue UAS (Unmanned Aerial System) certification.

Callaway Is Launching The Happy Gilmore 2 Limited Edition Odyssey Hockey Stick Putters and Golf Balls to Celebrate The Release Of The Highly Anticipated...

CARLSBAD, Calif. and LOS ANGELES, July 11, 2025 /PRNewswire/ -- Happy Gilmore 2 debuts on Netflix July 25th, and today in celebration of the...

China, Spain boost supply chain cooperation

BEIJING, July 11, 2025 /PRNewswire/ -- This is a report from China.org.cn The China-Spain Economic and Trade Forum and a roadshow for the third China International...

38 Special Mark 50th Anniversary With First Album in 20 Years, Milestone, out September 19

Watch the Music Video For Lead Single"All I Haven't Said" Touring This Summer and Fall Including Shows With KANSAS NEW YORK, July 11, 2025 /PRNewswire/ -- Today, 38...

BexBack Announces Double Deposit Bonus, 100x Leverage & No KYC as Bitcoin Surpasses $110,000

SINGAPORE, July 11, 2025 (GLOBE NEWSWIRE) -- The cryptocurrency market is in the midst of an explosive bull run, with Bitcoin recently breaking the $110,000 mark, sparking excitement and renewed interest among traders and investors globally. As the digital asset class continues to mature, BexBack Exchange is capitalizing on this surge by offering unrivaled trading conditions to both new and seasoned crypto traders.

Rakovina Therapeutics Congratulates Partner – Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award

Award Recognition underscores the importance of AI-driven drug discovery
Award Recognition underscores the importance of AI-driven drug discovery

DC Students to Get New Outdoor Adventure-Based Campus with $2M from Sunsetting Clark Foundation to Outward Bound School

Chesapeake Bay Outward Bound School and THEARC Partner to Launch Outdoor Campus in Southeast D.C. for Experiential Learning for Underserved Students  WASHINGTON, July 11, 2025...

Texas Papa Johns Locations to Donate 100% of Profits from All Orders on Tuesday, July 15th to Support Flood Relief Efforts in Texas Hill...

HOUSTON, July 11, 2025 /PRNewswire/ -- In response to the devastating flooding in the Texas Hill Country, Papa Johns Texas participating locations will be...

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion

– Absence of neurotoxicity of any grade in low-volume disease to-date –

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSource